Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2011-04-29 | Max E. Link, Ph.D. is Chairman, Director, age 70. He serves on Audit Committee, Compensation Committee, and Nominating and Governance Committee. 2010 Director Compensation Table shows total compensation of $121,395. |
| 2012-04-27 | Max E. Link, Ph.D., 71, Chairman, Director. The Audit Committee consists of Dr. Max Link, Chairman, Dr. Augustine Chow and Mr. Frederick J. Fritz. Mr. Hooper (Chairman) and Drs. Link and Martinez currently comprise the Compensation Committee. The current members of the Nominating and Governance Committee are Dr. Link, Chairman, and Dr. Martinez. 2011 Director Compensation Table shows Max E. Link total compensation $139,300. |
| 2013-06-07 | Dr. Link has served as a director of the Company since 1997 and has been the Chairman of the Board of Directors since October 2001. The Audit Committee consists of Dr. Max Link, Chairman, Dr. Augustine Chow and Mr. Frederick J. Fritz. Mr. Hooper (Chairman) and Drs. Link and Martinez currently comprise the Compensation Committee. The current members of the Nominating and Governance Committee are Dr. Link (Chairman) and Dr. Martinez. The 2012 Director Compensation Table shows Max E. Link with total compensation of $117,800. |
| Filing Date | Source Excerpt |
|---|---|
| 2010-11-15 | Dr. Link holds a Ph.D. in Economics from the University of St.Gallen, Switzerland. |
| 2011-08-15 | Max E. Link, Ph.D. has served as a member of our Board since October 1996. Dr. Link has held a number of executive positions with pharmaceutical and health care companies. He currently serves on the board of directors of three other publicly-traded life science companies: Alexion Pharmaceuticals, Inc., Celsion Corporation and CytRx Corporation. Until May 2008 he served as a director of Human Genome Sciences, Inc. Previously, Dr. Link served as Chairman and Chief Executive Officer of Centerpulse, Ltd.; as Chief Executive Officer of Corange Limited, the parent company of Boehringer Mannheim, now F. Hoffmann La Roche & CIE AG, and DePuy, Inc. Prior to that time, he served in a number of positions within Sandoz Pharma, Ltd., now Novartis Pharma, Ltd., including as Chief Executive Officer and as Chairman. Dr. Link holds a Ph.D. in Economics from the University of St.Gallen, Switzerland. |
| 2012-07-23 | Dr. Link holds a Ph.D. in Economics from the University of St.Gallen, Switzerland. |
Data sourced from SEC filings. Last updated: 2025-12-07